GREENWOOD CAPITAL ASSOCIATES LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1161822
GREENWOOD, SC
Position in HALO
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$606,749
+$107,806 QoQ
Shares Held
7,752
+0.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#360
of 661 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GREENWOOD CAPITAL ASSOCIATES LLC holds $17,673,711 across 9 Biotechnology names. HALO ranks #3 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,873 | $8,650,370 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,024 | $5,972,681 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
This page
|
7,752 | $606,749 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
1,495 | $555,646 | |
| 5 | EXEL |
Exelixis, Inc.
|
8,152 | $443,550 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
773 | $415,062 | |
| 7 | INCY |
Incyte Corp
|
3,319 | $376,241 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
6,121 | $333,839 |
All Filings in HALO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $606,749 | 7,752 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $498,943 | 7,720 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $525,141 | 7,803 | Shares | Sole | 2026-01-26 | |
| No filing history on record for this holder in this stock. | ||||||